Does Medicare Cover Breztri and Other COPD Inhalers? What You'll Pay in 2026

If you take Breztri Aerosphere for COPD and you're on Medicare, the short answer is: yes, most Medicare Part D plans cover it. But what you actually pay at the pharmacy varies wildly depending on which plan you're enrolled in. Some seniors pay $45 a month. Others get hit with $400+ until they hit the new out-of-pocket cap. The difference usually comes down to formulary placement and whether your plan requires prior authorization.

This guide walks through how Breztri (and inhalers like Trelegy, Anoro, Symbicort, and Advair) are covered under Medicare, what the 2026 changes mean for your wallet, and the legitimate ways to lower the price if your current plan is squeezing you.

Is Breztri covered by Medicare?

Breztri Aerosphere (a triple-therapy inhaler combining budesonide, glycopyrrolate, and formoterol) is a brand-name maintenance medication for COPD made by AstraZeneca. There's no generic version on the U.S. market as of 2026. Coverage works like this:

• Original Medicare (Part A and Part B alone) doesn't cover Breztri. Inhalers used at home are self-administered prescription drugs, which fall under Part D, not Part B.
• You need a Medicare Part D plan, either a standalone Prescription Drug Plan (PDP) added to Original Medicare, or a Medicare Advantage plan that includes drug coverage (MA-PD).
• Many Part D plans cover Breztri, but coverage varies by plan, formulary, pharmacy, and location. When covered, it's typically placed on a higher tier (Tier 3 or Tier 4, "non-preferred brand" or "preferred brand") rather than the lowest generic tiers.

The catch is that not every plan covers it the same way. Two seniors in the same ZIP code can pay very different prices for the exact same inhaler depending on which Part D plan they enrolled in.

How much does Breztri cost with Medicare?

Without insurance, Breztri's retail price runs roughly $700 to $800 for a one-month supply. With Medicare Part D, your out-of-pocket cost depends on three things:

1. Your plan's formulary tier for Breztri. Lower tiers cost less. Higher tiers can mean coinsurance of 25% to 40% rather than a flat copay.
2. Whether you've met your deductible. Many Part D plans apply a deductible (up to $615 in 2026) before any cost-sharing kicks in for non-preferred brand drugs.
3. Where you are in the coverage phases. Initial coverage, then the new $2,100 annual out-of-pocket cap, after which you pay $0 for covered drugs the rest of the year.

What the $2,100 Part D cap means for inhaler costs in 2026

In 2025, Medicare Part D introduced a hard cap on out-of-pocket prescription drug spending. For 2026, that cap is $2,100. Once your out-of-pocket spending for covered Part D drugs reaches that threshold, you pay $0 for covered Part D medications for the rest of the calendar year. For someone on a high-cost inhaler like Breztri (or specialty meds on top of it), this represents a real structural shift. The old "donut hole" coverage gap is gone.

You can also opt into the Medicare Prescription Payment Plan, which spreads your annual drug costs into smooth monthly installments instead of a few painful pharmacy bills early in the year.

Are inhalers and nebulizers covered by Medicare in general?

Coverage of respiratory equipment depends on what kind it is and where you use it. The rules differ in ways that surprise a lot of people:

If you're managing a complex respiratory condition, the difference between a Part B and a Part D bill matters. Part D copays count toward the $2,100 cap, while Part B coinsurance does not.

Why two plans quote wildly different Breztri prices

This is the most frustrating part for COPD patients shopping plans during Annual Enrollment. Three plan-level mechanisms cause the spread:

1. Formulary tier placement

Every Part D plan organizes covered drugs into tiers, typically 5 or 6. A plan that places Breztri on Tier 3 (Preferred Brand) might charge a $47 copay. A plan that places it on Tier 4 (Non-Preferred Brand) might charge 40% coinsurance, which on an $800 drug is $320. Same medication, different plan, drastically different cost.

2. Prior authorization

Some plans require your doctor to submit paperwork proving you've tried cheaper alternatives (step therapy) before they'll approve Breztri. If approval doesn't come through, the plan can refuse to fill it at the covered price. This is one of the most common reasons seniors get blindsided after switching plans.

3. Deductible structure

Some plans skip the deductible for low tiers but apply it fully to brand-name drugs. So your first Breztri fill of the year could cost the full deductible amount before normal cost-sharing kicks in.

How to pick a Part D plan when you take Breztri

The Medicare Plan Finder tool lets you enter your medications by name and dosage. It'll pull plans available in your ZIP code and project your full-year cost, including premium, deductible, copays, and where Breztri sits on each plan's formulary. A few habits that help:

• Always enter every medication you take, not just Breztri. The cheapest plan for one drug is often a terrible plan for another.
• Check for prior authorization or step therapy flags on Breztri specifically. The Plan Finder shows these.
• Look at the projected annual total, not just the monthly premium. A $0-premium plan with a $615 deductible and Tier 4 placement can cost more than a $40-premium plan with no deductible and Tier 3 placement.
• Run the comparison every year during AEP (October 15-December 7). Plans change formularies and tier placements annually. The plan that worked perfectly this year may move Breztri to a higher tier next year.

Not sure which Part D plan treats Breztri best in your ZIP code? A local independent Medicare agent can compare plans using your medication list and preferred pharmacy at no cost to you.

Ways to lower your Breztri cost

If your current plan is squeezing you, several options may help:

1. Apply for Extra Help (Low-Income Subsidy). If your income is below roughly 150% of the federal poverty level, the Extra Help program drops Part D copays to a few dollars per prescription regardless of tier.
2. Check the AstraZeneca patient assistance program. The drug's manufacturer offers an income-based program that can provide Breztri at low or no cost for patients who qualify. Medicare beneficiaries can sometimes use these alongside their Part D coverage.
3. Ask about a tier exception. Your prescriber can submit a request asking the plan to cover Breztri at a lower tier than its standard placement. Approvals aren't automatic but they happen, especially when documented medical necessity exists.
4. Don't rely on GoodRx blindly. A coupon price may look cheaper, but paying outside Part D means that spending doesn't count toward your $2,100 cap. Discount cards can quietly cost you more over the full year if you're on multiple expensive drugs.
5. Switch plans during AEP if your current one no longer fits. If Breztri moved to a higher tier or your plan added a prior auth requirement, you may have a better option for the upcoming year. Run a fresh Plan Finder comparison every fall.

What if your plan denies Breztri coverage?

Plans deny coverage for several reasons: formulary exclusion, missed prior authorization, step therapy not completed, or quantity limits. You have appeal rights. The process moves through five levels, starting with a redetermination request to your plan and escalating to an independent review entity if needed. Walk through the full process in our guide on how to appeal a denied Medicare claim. Appeals work more often than people expect when the prescriber documents medical necessity properly.

The bigger picture: COPD and your Medicare plan choice

Breztri is one piece of a broader question: does your Medicare setup actually fit the way you use healthcare? COPD typically involves regular pulmonologist visits, periodic imaging, possible hospitalizations during flare-ups, and ongoing prescriptions. The interaction between Part B specialist costs, Part D drug costs, and any Medigap or Medicare Advantage structure you have on top can add up to thousands of dollars in difference annually.

For a deeper look at how plan choice intersects with chronic respiratory conditions, see our companion guide on comparing Medicare plans for COPD. And if you want to weigh the tradeoffs between MA-PD and Original Medicare plus a standalone prescription drug plan, that decision often hinges on the same formulary details discussed above.

When to talk to a Medicare agent

Comparing 20+ Part D plans on a single drug is doable. Comparing them on a list of five medications, factoring in your preferred pharmacy, projected annual total cost, and prior authorization risk? That's where most people get stuck. A licensed independent Medicare agent can pull the same Plan Finder data, narrow the field to the two or three best fits, and flag risks like "this plan is dropping Breztri coverage next year" before you enroll.

Agents are paid by insurance carriers, not by you, so the consultation costs nothing out of pocket. The catch is making sure you're working with someone independent who represents multiple carriers rather than a captive agent for a single company. Find a local independent Medicare agent who can run the comparison with your specific medication list.

Frequently asked questions

Is there a generic version of Breztri?
No. As of 2026, Breztri Aerosphere has no generic equivalent. Other triple-therapy COPD inhalers like Trelegy Ellipta are also brand-only. Doctors sometimes use combinations of separate inhalers as alternatives, but those have their own coverage rules.

Will Medicare ever negotiate Breztri's price?
The Inflation Reduction Act gave Medicare authority to negotiate prices on a limited list of high-spend drugs. Breztri was not selected in the first or second rounds of Medicare drug price negotiation. It could be considered in a future round, but beneficiaries should not assume a near-term price reduction.

Can I use a manufacturer coupon with Medicare?
Manufacturer copay coupons generally can't be used with Medicare Part D under federal anti-kickback rules. Patient assistance programs (separate from coupons) often can be used, but the rules vary by program. Check directly with AstraZeneca's program eligibility requirements.

Does Medicare Advantage cover Breztri differently than standalone Part D?
Not categorically. Both use the same tier-and-formulary framework. The difference is that MA-PD plans may also affect what you pay for related care (pulmonologist visits, hospital stays for COPD flare-ups), so the total picture matters more than just the inhaler price.

Where can I check if my specific plan covers Breztri right now?
Log into your plan's member portal or call the number on your Part D card and ask: "Is Breztri Aerosphere on the formulary, what tier is it, and does it require prior authorization?" You can also use the Medicare Plan Finder to verify before AEP.

The bottom line

Medicare covers Breztri through Part D, but coverage isn't the same as affordability. The plan you pick (and the year you picked it) determines whether you're paying $45 a month or several hundred. Run the Medicare Plan Finder with your full medication list every AEP, watch for tier changes and prior authorization rules, and don't ignore Extra Help if your income qualifies. The 2026 $2,100 out-of-pocket cap is a real ceiling, which makes choosing the right plan less about whether you can afford the drug and more about how quickly you'll hit that cap and stop paying altogether.